Correction: Obesity drug story
By APMonday, December 28, 2009
Correction: Obesity drug story
NEW YORK — In a Dec. 22 story about obesity drugs, The Associated Press erroneously reported when Orexigen Therapeutics Inc. plans to file for approval of its drug candidate Contrave32. It plans to file in the first half of 2010, not by the end of the year.
Filed under: Obesity
Tags: Diagnosis And Treatment, Diseases And Conditions, Medication, New York, North America, United States
Tags: Diagnosis And Treatment, Diseases And Conditions, Medication, New York, North America, United States
YOUR VIEW POINT
